Details for New Drug Application (NDA): 080429
✉ Email this page to a colleague
The generic ingredient in ANESTACON is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
Summary for 080429
Tradename: | ANESTACON |
Applicant: | Bionpharma |
Ingredient: | lidocaine hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | JELLY;TOPICAL | Strength | 2% | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription